Our Science

As we focus on providing leading inhalation services, we’re looking forward to sharing our scientific content with you.
We’ll be updating this regularly with useful information so subscribe below to keep informed.

Displaying 7 of 7

Brochure
Our Development Science, Technology and Capabilities

From pre-clinical development to commercialisation, see how Vectura’s formulation science, device technology and development expertise can help your development programme

AuthorVectura

Published23/06/2020

Read more
Publication
Particle size distribution, delivered dose and lung deposition of two mesh nebulisers guiding patients on slow and deep inhalation

This poster investigates the performance of the FOX® device and compares it with another mesh nebuliser.

AuthorMüllinger, B. et al

Published11/12/2019

Read more
Publication
Sedimentation or Creaming: Assessment of pMDI Suspensions’ Behaviour

This poster highlights characterisation techniques for pMDI suspension formulations in early product development. We describe a fast and efficient means...

AuthorAbdrabo, S. et al

Published11/12/2019

Read more
Publication
Enhanced Lung Deposition when using a Smart Nebuliser Instead of a Conventional Nebuliser

This poster shows the potential for Vectura’s AKITA® Jet smart nebuliser to achieve both higher and deeper lung deposition when...

AuthorMunro, S. et al

Published11/12/2019

Read more
Publication
Dry Powder Deposition on a Multiple-Use Device

This poster describes the typical challenges anticipated during the development of a biologic as a dry powder inhaler (DPI) product,...

AuthorGower, F. et al

Published11/12/2019

Read more
Publication
Development and Verification of a Process to Assess Electrostatic Charge Build-up on an Inhaler

This poster highlights the challenges of patient-generated static on the lever-operation multi-dose dry powder inhaler (LOMI) device in a laboratory...

AuthorCarne, S. & Hinton, J.

Published11/12/2019

Read more
Brochure
Vectura – Our Focus on Inhalation

Vectura builds on its track record with a new focus as an inhalation CDMO, helping companies bring their medicines to...

AuthorVectura

Published20/01/2020

Read more

Displaying 7 of 7

Subscribe to our science newsletter